Related Experiment Video
Updated: Jul 6, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Rictor and integrin-linked kinase interact and regulate Akt phosphorylation and cancer cell survival
Paul C McDonald1, Arusha Oloumi, Julia Mills
1Department of Cancer Genetics, BC Cancer Research Centre, British Columbia Cancer Agency, Vancouver, BC, Canada.
Abstract:
An unbiased proteomic screen to identify integrin-linked kinase (ILK) interactors revealed rictor as an ILK-binding protein. This finding was interesting because rictor, originally identified as a regulator of cytoskeletal dynamics, is also a component of mammalian target of rapamycin complex 2 (mTORC2), a complex implicated in Akt phosphorylation. These functions overlap with known ILK functions. Coimmunoprecipitation analyses confirmed this interaction, and ILK and rictor colocalized in membrane ruffles and leading edges of cancer cells. Yeast two-hybrid assays showed a direct interaction between the NH(2)- and COOH-terminal domains of rictor and the ILK kinase domain. Depletion of ILK and rictor in breast and prostate cancer cell lines resulted in inhibition of Akt Ser(473) phosphorylation and induction of apoptosis, whereas, in several cell lines, depletion of mTOR increased Akt phosphorylation. Akt and Ser(473)P-Akt were detected in ILK immunoprecipitates and small interfering RNA-mediated depletion of rictor, but not mTOR, inhibited the amount of Ser(473)P-Akt in the ILK complex. Expression of the NH(2)-terminal (1-398 amino acids) rictor domain also resulted in the inhibition of ILK-associated Akt Ser(473) phosphorylation. These data show that rictor regulates the ability of ILK to promote Akt phosphorylation and cancer cell survival.
Insights
Rictor binds to integrin-linked kinase (ILK), regulating Akt phosphorylation and promoting cancer cell survival. This interaction is crucial for ILK
Area of Science:
- Cell Biology
- Molecular Oncology
- Signal Transduction
Background:
- Integrin-linked kinase (ILK) is a key regulator of cellular processes.
- Rictor is a component of mTORC2, involved in Akt phosphorylation.
- ILK and rictor share overlapping functions in cytoskeletal dynamics and cell signaling.
Purpose of the Study:
- To identify novel ILK-binding proteins.
- To investigate the functional interaction between ILK and rictor.
- To elucidate the role of the ILK-rictor complex in cancer cell signaling and survival.
Main Methods:
- Unbiased proteomic screening
- Coimmunoprecipitation assays
- Yeast two-hybrid assays
- siRNA-mediated gene depletion
- Western blotting for Akt phosphorylation
Main Results:
- Rictor was identified as a direct ILK-binding protein.
- ILK and rictor colocalize in cancer cells and interact directly.
- Depletion of ILK or rictor inhibits Akt Ser(473) phosphorylation and induces apoptosis.
- Rictor, not mTOR, regulates Akt phosphorylation within the ILK complex.
Conclusions:
- Rictor is a critical regulator of ILK-mediated Akt phosphorylation.
- The ILK-rictor interaction is essential for cancer cell survival.
- Targeting the ILK-rictor complex may offer therapeutic strategies for cancer.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Intracellular Signaling Affects Focal Adhesions
Some...
Receptor Tyrosine Kinases
Inhibition of Cdk Activity